home / stock / bdtx / bdtx articles

BDTX Articles, Black Diamond Therapeutics Inc.

Stock Information
Company Name: Black Diamond Therapeutics Inc.
Stock Symbol: BDTX
Market: NASDAQ
Website: blackdiamondtherapeutics.com
Menu
BDTX BDTX Quote BDTX Short BDTX News BDTX Articles BDTX Message Board
Get BDTX Alerts

News, Short Squeeze, Breakout and More Instantly...
Black Diamond Therapeutics Announces Presentations at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | Benzinga

CAMBRIDGE, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage oncology company developin...
Black Diamond Therapeutics Announces Upcoming Presentation at AACR Annual Meeting 2024 | Benzinga

CAMBRIDGE, Mass., March 05, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage oncology company developi...

Black Diamond Therapeutics to Participate in the TD Cowen 44th Annual Health Care Conference | Benzinga

CAMBRIDGE, Mass., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage oncology company developing...

Black Diamond Therapeutics And 2 Other Stocks Under $3 Insiders Are Buying | Benzinga

The Dow Jones closed lower by around 250 points on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around...
Black Diamond Therapeutics to Present Preclinical and Clinical Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics | Benzinga

CAMBRIDGE, Mass. and NEW YORK, Oct. 04, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage precision onco...

Black Diamond Therapeutics Announces CEO Transition | Benzinga

Current Chairman of the Board and industry veteran Mark Velleca appointed CEO CAMBRIDGE, Mass. and NEW YORK, Sept. 18, 2023 (GLOBE NEWSWIRE) -- ...

Black Diamond Therapeutics to Participate in Upcoming Investor Conferences | Benzinga

CAMBRIDGE, Mass. and NEW YORK, Sept. 05, 2023 (GLOBE NEWSWIRE) -- Black Diamond Therapeutics, Inc. (NASDAQ:BDTX), a clinical-stage precision onc...
Next 10